Breaking News

Will the third time be the charm for Amazon?

Not rendering correctly? View this email as a web page here.

How Behavioral Healthcare Practices Can Reduce No-show Appointments

By Ram Krishnan Friday, November 18, 2022 5:43 PM

By taking a few simple steps, practices can help ensure that their patients get the care they need while reducing unnecessary losses of revenue and time within the business model.

Read more »

The Impending Shift in the Delivery of Cardiac Care Creates Opportunities for Physicians and Hospitals

By Daniel B. Frier and Theresa M. DiGuglielmo Friday, November 18, 2022 4:35 PM

The shifting of services to outpatient settings will likely cause hospitals to unwind their contractual relationships with cardiologists, sending the physicians back into private practice. Astute hospital administrators will have already anticipated the migration of cardiologists away from hospital inpatient care and started to prepare for a different type of alignment with cardiologists.

Read more »

Non-profit Sues FDA, Requesting the Agency Withdraw Approval for Abortion Drugs

By Amanda James Friday, November 18, 2022 4:34 PM

The group complains that the FDA never studied the safety of the drugs under the labeled conditions of use. 

Read more »

Kaiser Nurses Avert Strike and Get 22.5% Raise With New Contract

By Katie Adams Friday, November 18, 2022 3:13 PM

About 22,000 nurses and nurse practitioners reached a tentative agreement with Kaiser Permanente,, averting what would have been the biggest private sector nurses strike in American history. These workers have been in negotiations since June, but they will soon vote to ratify a new four-year contract, which includes provisions for a 22.5% raise, increased nurse staffing and more.

Read more »

Provention Wins FDA Approval for First Drug to Delay Type 1 Diabetes Progression

By Frank Vinluan Friday, November 18, 2022 2:51 PM

Type 1 diabetes patients now have a new therapeutic option for the autoimmune disorder. Provention Bio drug Tzeild has received FDA approval for delaying the onset of the most severe stage of this chronic disease.

Read more »

   

No comments